Substance / Medication

Oxiconazole

Overview

Active Ingredient
oxiconazole
RxNorm CUI
32638

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effects of poly- and monodisperse surfactants on 14C-epoxiconazole diffusion in isolated cuticles of Prunus laurocerasus.
Gutenberger Andrea, Zeisler Viktoria V, Berghaus Rainer et al. · Pest Manag Sci · 2013
PMID: 23044821Observational
Effects of topical oxiconazole and boric acid in alcohol solutions to rat inner ears.
Özdemir Süleyman, Tuncer Ülkü, Tarkan Özgür et al. · Otolaryngol Head Neck Surg · 2013
PMID: 23482479Observational
Ototoxic effect of topical oxiconazole and terbinafine in rats.
Aydın Emine, Taştan Eren, Aydoǧan Filiz et al. · J Otolaryngol Head Neck Surg · 2012
PMID: 22569007Observational
Antileishmanial activity of benzocycloalkyl azole oximino ethers: the conformationally constraint analogues of oxiconazole.
Verma Aditya, Srivastava Saumya, Sane Shraddha A et al. · Acta Trop · 2011
PMID: 21078278Observational
Spectrophotometric determination of oxiconazole in topical lotion using methyl orange.
Milano Julie, Cardoso Simone Gonçalves · J Pharm Biomed Anal · 2005
PMID: 15797782Observational
LC method for the analysis of Oxiconazole in pharmaceutical formulations.
Milano Julie, Morsch Lisoni M, Cardoso Simone Gonçalves · J Pharm Biomed Anal · 2002
PMID: 12191701Observational
Synchronous dual-mode sensing platform based on 1D chiral ionic COF for epoxiconazole detection.
Ruan Yeqian, Zheng Xiaodong, Kuang Xuan et al. · Analyst · 2026
PMID: 41536198Other
Enantioselective hepatotoxicity of rac- epoxiconazole and epoxiconazole enantiomers in lizards (Eremias argus).
An Qiong, Hao Weiyu, Zhang Leisen et al. · J Hazard Mater · 2025
PMID: 40916297Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Oxiconazole (substance)
SNOMED CT
372778004
UMLS CUI
C0069765
RxNorm CUI
32638

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.